Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy
Condition(s) studied
Study summary
The goal of this national mutlticenter observational study is to learn and describe trends over time in the use of techniques for inducing hepatic hypertrophy in Italy. Patients will be treated according to the current clinical practice of the participating centers and will be observed from the moment of recruitment and throughout their stay. Information on vital status will be collected, as far as possible, for up to 5 years after surgery in order to record any events that occur in a timely manner. There are also plans to retrospectively collect data on patients who underwent hypertrophic techniques in the previous 10 years, in order to establish a historical cohort for each center that can be used for comparison with the prospective cohort.
Eligibility
Primary outcome measure(s)
- Describe the temporal trends in the use of techniques for inducing hepatic hypertrophy in Italy — through study completion, an average of 1 year
- compare the techniques used in terms of function and volumetric hypertrophy — through study completion, an average of 1 year
- compare the techniques used in terms of drop-out — through study completion, an average of 1 year
- compare the techniques used in terms of 90-day mortality — through study completion, an average of 1 year
- compare the techniques used in terms of long-term survival — through study completion, an average of 1 year
- compare the techniques used in terms of disease-free survival — through study completion, an average of 1 year
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| IRCCS Azienda Ospedaliero-Universitario di Bologna | Bologna | Bologna | Recruiting |
More IRCCS Azienda Ospedaliero-Universitaria di Bologna trials in Italy
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07445412 on ClinicalTrials.gov ↗ ← All trials in Italy